I. Timofte

894 total citations
40 papers, 332 citations indexed

About

I. Timofte is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I. Timofte has authored 40 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 17 papers in Transplantation and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I. Timofte's work include Transplantation: Methods and Outcomes (35 papers), Renal Transplantation Outcomes and Treatments (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). I. Timofte is often cited by papers focused on Transplantation: Methods and Outcomes (35 papers), Renal Transplantation Outcomes and Treatments (17 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers). I. Timofte collaborates with scholars based in United States, Australia and Canada. I. Timofte's co-authors include Aldo Iacono, Sean Agbor-Enoh, Pali D. Shah, Bartley P. Griffith, Anne Brown, Jonathan B. Orens, Steven D. Nathan, Pablo G. Sánchez, Si M. Pham and Moon Kyoo Jang and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and The Annals of Thoracic Surgery.

In The Last Decade

I. Timofte

31 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Timofte United States 10 286 207 56 47 37 40 332
Saskia Bos Belgium 9 251 0.9× 102 0.5× 94 1.7× 33 0.7× 39 1.1× 31 295
Chatchai Kreepala Thailand 7 228 0.8× 321 1.6× 77 1.4× 20 0.4× 52 1.4× 15 460
Paul Warner United States 13 186 0.7× 236 1.1× 15 0.3× 37 0.8× 34 0.9× 29 398
M. Pipkin United States 11 159 0.6× 59 0.3× 80 1.4× 19 0.4× 20 0.5× 38 288
G.-C. Park South Korea 14 416 1.5× 95 0.5× 28 0.5× 40 0.9× 164 4.4× 29 517
K.B. Bain United States 6 217 0.8× 160 0.8× 26 0.5× 42 0.9× 33 0.9× 7 255
T. Beuscart France 4 323 1.1× 421 2.0× 55 1.0× 22 0.5× 44 1.2× 4 492
Annemie Vaneylen Belgium 8 230 0.8× 60 0.3× 162 2.9× 31 0.7× 95 2.6× 14 314
Mohammed F. Shaheen Saudi Arabia 8 105 0.4× 75 0.4× 21 0.4× 29 0.6× 57 1.5× 21 223
Anna Rossetto Italy 12 200 0.7× 66 0.3× 61 1.1× 43 0.9× 95 2.6× 33 331

Countries citing papers authored by I. Timofte

Since Specialization
Citations

This map shows the geographic impact of I. Timofte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Timofte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Timofte more than expected).

Fields of papers citing papers by I. Timofte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Timofte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Timofte. The network helps show where I. Timofte may publish in the future.

Co-authorship network of co-authors of I. Timofte

This figure shows the co-authorship network connecting the top 25 collaborators of I. Timofte. A scholar is included among the top collaborators of I. Timofte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Timofte. I. Timofte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Younis, Muhammad, Charles M. Miller, Pragya Kumar, et al.. (2025). Impact of Conversion to a Belatacept-Based Immunosuppression as a Calcineurin Sparing Regimen in Lung Transplant on Donor Specific Antibodies: A Multi-Institutional Retrospective Study. The Journal of Heart and Lung Transplantation. 44(4). S72–S72.
2.
Timofte, I., Vaidehi Kaza, Srinivas Bollineni, et al.. (2024). Inhaled Cyclosporine-Based Immunosuppression Regimen Can Decrease Systemic Calcineurin Inhibitors Nephrotoxicity in Lung Transplant Patients. The Journal of Heart and Lung Transplantation. 43(4). S336–S336.
3.
Brandon, William, Song Zhang, Ang Gao, et al.. (2024). Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience. Clinical Transplantation. 38(10). e15461–e15461. 1 indexed citations
4.
Torres, Fernando, Vaidehi Kaza, Srinivas Bollineni, et al.. (2024). Outpatient management of Post-COVID syndrome – single center experience. Heart & Lung. 67. 137–143.
5.
6.
Brandon, William, Srinivas Bollineni, Manish Mohanka, et al.. (2023). Management of donor-specific antibodies in lung transplantation. SHILAP Revista de lepidopterología. 2. 1248284–1248284.
7.
Bollineni, Srinivas, I. Timofte, Fernando Torres, et al.. (2022). COVID-19 Vaccination is Associated With Favorable Outcomes Among Lung Transplant Patients With Breakthrough Infections. Transplantation Proceedings. 54(6). 1517–1523. 2 indexed citations
8.
Bollineni, Srinivas, Manish Mohanka, I. Timofte, et al.. (2021). Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID‐19. Transplant Infectious Disease. 24(2). e13784–e13784. 9 indexed citations
9.
Permpalung, Nitipong, Kai Yu, I. Timofte, et al.. (2021). Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury. The Journal of Heart and Lung Transplantation. 40(11). 1454–1462. 18 indexed citations
10.
Keller, Michael, Errol L. Bush, Joshua M. Diamond, et al.. (2021). Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD). The Journal of Heart and Lung Transplantation. 40(6). 488–493. 35 indexed citations
11.
Keller, Michael, Junfeng Sun, Pali D. Shah, et al.. (2021). Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care. The Journal of Heart and Lung Transplantation. 41(4). 458–466. 30 indexed citations
12.
Jang, Moon Kyoo, Ilker Tunc, Gerald J. Berry, et al.. (2021). Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study. The Journal of Heart and Lung Transplantation. 40(8). 822–830. 56 indexed citations
13.
Timofte, I., Roumen Vesselinov, June Kim, et al.. (2020). Survival benefit of lung transplantation compared with medical management and pulmonary rehabilitation for patients with end-stage COPD. ERJ Open Research. 6(2). 177–2019. 3 indexed citations
14.
Halloran, K., Michael Parkes, I. Timofte, et al.. (2020). Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss. The Journal of Heart and Lung Transplantation. 39(12). 1327–1337. 13 indexed citations
15.
Timofte, I., Adriano R. Tonelli, Montserrat Diaz‐Abad, et al.. (2020). Gait-speed and oxygen flow during six-minute walk test predicts mortality in patients with advanced lung disease. SHILAP Revista de lepidopterología. 90(1). 3 indexed citations
16.
Iacono, Aldo, et al.. (2019). A randomised single-centre trial of inhaled liposomal cyclosporine for bronchiolitis obliterans syndrome post-lung transplantation. ERJ Open Research. 5(4). 167–2019. 23 indexed citations
17.
Halloran, K., Michael Parkes, I. Timofte, et al.. (2019). Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants. American Journal of Transplantation. 20(4). 954–966. 27 indexed citations
18.
Evans, Charles F., Aldo Iacono, Pablo G. Sánchez, et al.. (2015). Venous Thromboembolic Complications of Lung Transplantation: A Contemporary Single-Institution Review. The Annals of Thoracic Surgery. 100(6). 2033–2040. 30 indexed citations
19.
Timofte, I., M. Crespo, C. Bermúdez, et al.. (2013). Addition of Rapamycin to the Immunosuppressant Regimen Improves Airway Patency in Lung Transplant Patients With Refractory Bronchial Stenosis. CHEST Journal. 144(4). 1014A–1014A. 4 indexed citations
20.
Timofte, I., Adriano R. Tonelli, Olufemi Akindipe, & Maher Baz. (2010). Six-Minute Walk Test and Mortality in Patients With Advanced Lung Disease. CHEST Journal. 138(4). 544A–544A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saskia Bos Breakdown of academic impact, for papers by Chatchai Kreepala Breakdown of academic impact, for papers by Paul Warner Breakdown of academic impact, for papers by M. Pipkin Breakdown of academic impact, for papers by G.-C. Park Breakdown of academic impact, for papers by K.B. Bain Breakdown of academic impact, for papers by T. Beuscart Breakdown of academic impact, for papers by Annemie Vaneylen Breakdown of academic impact, for papers by Mohammed F. Shaheen Breakdown of academic impact, for papers by Anna Rossetto
Rankless by CCL
2026